-
Comment Letter
Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
- Denis Y Logunov, Inna V Dolzhikova, Amir I Tukhvatullin, and Dmitry V Shcheblyakov.
- N F Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow 123098, Russia. Electronic address: ldenisy@gmail.com.
- Lancet. 2020 Oct 3; 396 (10256): e54-e55.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.